Patent · US Active

Manufacture of trans-[tetrachlorobis(1H-indazole)ruthenate (III)] and compositions thereof

US11040993B2 · kind B2 · utility

2Cited by

2References

31Claims

0Family size

Assignee

Bold Therapeutics, Inc. · CA

Inventors

Tomas Vojkovsky · North Palm Beach, US
Kevin N. Sill · Tampa, US
Adam Carie · Tampa, US

Key dates

Filing date	Feb 4, 2020
Grant date	Jun 22, 2021
Priority date	—
Expiry date	Feb 4, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the preparation of compositions comprising sodium trans-[tetrachlorobis(1H-indazole)ruthenate (III)]. Synthesis and formulation preparation is detailed. Impurity profiles are also discussed. Compositions herein are useful for anti-cancer applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.